C8 Octanoyl

C8 octanoyl, also called octanoylcarnitine, is one of the acylcarnitines measured in blood to assess how your body breaks down medium-chain fats for energy. It reflects the amount of an eight-carbon fatty acid group linked to carnitine, a carrier molecule that helps shuttle fats into mitochondria.

This test is commonly included in newborn screening panels and in metabolic evaluations. It is usually measured by tandem mass spectrometry on a blood sample or a dried blood spot and is interpreted together with other acylcarnitines and clinical information.

Doctors look at C8 octanoylcarnitine to help detect disorders of fatty acid oxidation, especially reduced activity of the enzyme medium-chain acyl-CoA dehydrogenase. When this marker is higher than expected, it can point to a problem using medium-chain fats for energy, which may lead to low blood sugar and illness during fasting or stress. It can also rise with certain diets, supplements, or medications, so context matters.

The test is often ordered as part of newborn screening, for symptoms such as unexplained low blood sugar or lethargy, or to monitor known metabolic conditions. Results help guide follow-up testing, nutrition plans to avoid fasting, and emergency care strategies during illness.

Your result is interpreted by your clinician in the context of age, diet, recent health, medications, and other lab findings. If the value is elevated, your care team may order confirmatory tests such as a repeat acylcarnitine profile, urine organic acids, and genetic testing to clarify the cause and to plan treatment.

If results are borderline or unexpected, your clinician may repeat testing after recovery from an illness or after adjusting diet or medications that can influence acylcarnitines. A result in the expected range is reassuring, but it may not completely rule out a mild metabolic condition. Follow your clinician’s guidance on next steps, which may include nutritional counseling and an action plan for times of stress or illness.